Investors have been flocking to the worldwide biotech sector over the past few years amid high returns and as a result initial public offerings in the sector have also attracted strong interest. But sentiment has now begun to change from last year amid the broader stock market weakness globally.
Bracing For The Cold: Time For Korean Bioventures To Cut Down
Select And Focus Strategy Recommended
A recent forum in South Korea heard from a venture capital executive about the changing IPO and financing environment and how bioventures might be able to cope with these changes.
